Skip to main content
Premium Trial:

Request an Annual Quote

New Products: NanoString's Single Cell Gene Expression Application, Genalyte's Custom Spotting Service, InDevr's Custom Arrays

Premium

NanoString Technologies this week launched an application for single-cell gene-expression profiling.

The new application enables digital measurement of the expression of up to 800 unique transcripts and the firm claims its approach offers "superior performance" to standard single-cell microfluidic qPCR protocols.

NanoString also claims its single-tube multiplexed assay eliminates sample splitting and "frees researchers from the constraints of fixed-format consumables employed by existing technologies, allowing them to assay genes based on the biology."

The new application runs on NanoString's nCounter Analysis System, a fully automated, multi-application digital detection and counting instrument. The nCounter currently supports assays for gene expression, miRNA analysis, and copy number variation.


Genalyte last week launched its custom spotting service. As part of the service, the company will load proteins such as antibodies, peptides, biomarkers, cytokines, and antigens supplied by customers onto Genalyte chips.

The chips will then be returned to the customer in the same format used in Genalyte's catalog multiplex assay kits and will be ready to be run on its Maverick Detection System. The Maverick platform processes silicon chips containing arrays of photonic microring sensors to analyze multiple biomolecules, according to the firm.

Genalyte has also announced a co-marketing agreement with Scienion. Under that agreement, Genalyte will market Scienion's SciFlexArrayer S5 together with its Maverick system. Scienion's SciFlexArrayers are automated non-contact dispensing systems for ultra-low volume liquid handling of biological samples.


InDevr this week said that it now offers custom array services.

The Boulder, Colo.-based compant said it provides flexible array placement, printing of capture agents, and spotting of up to 850 unique oligos per array, each of which are available and compatible with InDevr's AmpliPhox and other detection systems.

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.